Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 3/20 | 0.61 |
| ▸ | GABRD | O14764 | 3/20 | 0.61 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.61 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.61 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.61 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.61 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.61 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.61 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.61 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.61 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.61 |
| ▸ | GABRE | P78334 | 3/20 | 0.61 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.61 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 0.61 |
| ▸ | GABRG3 | Q99928 | 3/20 | 0.61 |
| ▸ | GABRQ | Q9UN88 | 3/20 | 0.61 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.59 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30490061 | 1.00 | GABRP (0.61) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Ammonia Solution, Strong SCHEMBL28481259 | 0.98 | GABRP (0.59) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31619545 | 0.86 | ERCC5 (0.53) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6009055 | 0.86 | ERCC5 (0.53) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL24032722 | 0.84 | GABRP (0.55) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31714622 | 0.84 | ALDH1A1 (0.61) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9709372 | 0.84 | ALDH1A1 (0.61) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL24723178 | 0.84 | IMPDH2 (0.52) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL23487188 | 0.82 | DYRK1A (0.57) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL20276479 | 0.81 | ERCC5 (0.50) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117092262-A | Analysis method for detecting 11 carbazole and halogenated derivatives thereof in shellfish | 舟山市食品药品检验检测研究院 | 2023-11-21 | — | — | CN | claimed |
| CN-107935913-A | Carbazole compound and its synthetic method and application | 华东师范大学 | 2018-04-20 | — | — | CN | claimed |
| CN-116283725-B | Aromatic amine substituted dibenzofive-membered ring compound and application thereof | 烟台显华科技集团股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| WO-2024228554-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2024-11-07 | — | — | WO | disclosed |
| WO-2024225580-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2024-10-31 | — | — | WO | disclosed |
| CN-116003389-B | Organic electroluminescent compounds and use thereof | 宁波卢米蓝新材料有限公司 | 2024-09-27 | — | — | CN | disclosed |
| US-20240251665-A1 | TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOSOH CORPORATION (JP) | 2024-07-25 | — | — | US | disclosed |
| CN-117092262-B | Analysis method for detecting 11 carbazole and halogenated derivatives thereof in shellfish | 舟山市食品药品检验检测研究院 | 2024-05-28 | — | — | CN | disclosed |
| CN-113260608-B | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-12-12 | — | — | CN | disclosed |
| CN-117092262-A | Analysis method for detecting 11 carbazole and halogenated derivatives thereof in shellfish | 舟山市食品药品检验检测研究院 | 2023-11-21 | — | — | CN | disclosed |
| CN-117044428-A | Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element | 东曹株式会社 | 2023-11-10 | — | — | CN | disclosed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| EP-2772483-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | Tosoh Corporation (JP) | 2014-09-03 | — | — | EP | disclosed |
| CN-104011022-A | 4-aminocarbazole compound and use of same | TOSOH CORP | 2014-08-27 | — | — | CN | disclosed |
| US-20060183022-A1 | Electrochemical cell | NEC TOKIN CORORATION (JP) | 2006-08-17 | — | — | US | disclosed |
| CN-1050604-C | Compound with antipsychotic effect | MEIJI SEIKA KABUSHIKA KAISHA (JP) | 2000-03-22 | — | — | CN | disclosed |
| US-5599815-A | SIDE EFFECT REDUCTION | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1997-02-04 | — | — | US | disclosed |
| CN-1103534-A | Compound with antipsychotic effect | MEIJI SEIKA CO (JP) | 1995-06-07 | — | — | CN | disclosed |
| EP-0635506-A1 | COMPOUND WITH ANTIPSYCHOTIC EFFECT | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1995-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240251665-A1 | TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT | AXIN2, FZD7, SLC39A3 | GABRP 2924/4885GABRD 1857/4885GABRA1 1247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.